Trial Profile
A Randomized Trial of Apalutamide in Non-Muscle Invasive Bladder Cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Feb 2024
Price :
$35
*
At a glance
- Drugs Apalutamide (Primary)
- Indications Bladder cancer; Carcinoma
- Focus Therapeutic Use
- 27 Jan 2024 Planned End Date changed from 15 Dec 2026 to 15 May 2027.
- 27 Jan 2024 Planned primary completion date changed from 15 Jun 2026 to 15 Nov 2026.
- 27 Jan 2024 Planned initiation date changed from 15 Jan 2024 to 15 Jun 2024.